Stroke Patients with Hemiplegic Shoulder Pain Stroke, Hemiplegic Shoulder Pain, Scapular Mobilization, Soft Tissue Release, Upper Limb Function
Conditions
Interventions
Scapular Mobilization program 6 repittion 3 round for 6 weeks,Conventional PT 2 day per week for 6 weeks
Experimental Other,Active Comparator Other
Scapular Mobilization program,Control group
Sponsors
Medical Research Fund
Eligibility
Sex/Gender
All
Age
20 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: 1.First-ever stroke patients presenting with hemiplegia and paretic shoulder pain, with or without secondary joint stiffness in the shoulder, elbow, wrist, or fingers. The duration onset of hemiparesis must not exceed 1 year prior to enrollment, with a shoulder pain score between 4 and 7 on the Visual Analog Scale (VAS). 2.Able to communicate effectively in Thai. 3.Capable of understanding and following instructions well. 4.Aged between 20 and 75 years. 5.Patients currently undergoing standard physical therapy care are eligible to participate. 6.Motor recovery level of the paretic upper extremity, assessed by the Brunnstrom Stage of Motor Recovery, ranging from Stage 1 (flaccid, no voluntary movement) to Stage 4 (spasticity decreases, capable of lateral pinch, minor finger extension, and emerging complex movement patterns). 7.Functional level in basic activities of daily living, assessed by the Barthel Index, with total scores ranging from 5 to 20 (severe dependence to independence). 8.Upper extremity motor function impairment level, assessed by the Fugl-Meyer Assessment of Upper Extremity (FMA-UE), with a score less than or equal to 33 (indicating mild to moderate motor capacity/severe to moderate impairment).
Exclusion criteria
Exclusion criteria: 1.A history of shoulder injury, shoulder pain, or adhesive capsulitis, as well as pain or injury involving the elbow, wrist, or hand, prior to the onset of stroke. 2.Receipt of botulinum toxin injections into the trapezius, pectoralis, or subscapularis muscles within 3 months prior to study enrollment. 3.Receipt of any treatment for shoulder pain within 3 months prior to study enrollment, including analgesic medications, intra-articular corticosteroid injections, acupuncture, or electrical stimulation therapy. 4.A history of other neurological disorders or injuries that may affect upper limb function, such as cervical spondylosis, traumatic brain injury, or brain tumor. 5.Presence of unilateral neglect. 6.Shoulder pain attributable to Complex Regional Pain Syndrome (CRPS). 7.Shoulder subluxation on the affected side measuring than 1 finger breadth (than 1 FB). 8.Bleeding disorders or conditions associated with an increased risk of bleeding, such as thrombocytopenia, hemophilia, or treatment with anticoagulant medications ( warfarin) with an International Normalized Ratio (INR) than 3.0 9/Comorbidities that may increase the risk of musculoskeletal complications, such as cancer or osteoporosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity Before, 4 and 6 week after program VAS | — |
Secondary
| Measure | Time frame |
|---|---|
| Shoulder range of motion Before, 4 and 6 week after program Shoulder ROM,Upper limbs function Before, 4 and 6 week after program Fugl Meyer assessment UE | — |
Countries
Thailand
Contacts
Public ContactTussaneeporn Soison
Faculty of Medicine, PSU
Outcome results
None listed